Pulmonary aspects in alpha-1-antitrypsin deficiency;Aspectos pulmonares na deficiência de alfa-1-antitripsina

Revista Portuguesa de Pneumologia

Volumn 10, Issue 2, 2004, Pages 145-154

  Schmid Melo Neto, Luiza ́Erika ^a   Teixeira da Silva Jr , Cyro ^a   Perez Cardoso, Gilberto ^a   Santos Ferreira, Ângela ^a   da Costa Marino, Guilherme ^a   Monteiro, Nicolau Pedro ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

Author keywords

Alpha 1 antitripysin; Chronic obstructive pulmonary disease

Indexed keywords

ALPHA 1 ANTITRYPSIN; PROTEINASE INHIBITOR;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; AUTOSOMAL DISORDER; CAUCASIAN; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; EUROPE; FREQUENCY ANALYSIS; HUMAN; LABORATORY TEST; LUNG DISEASE; LUNG FIBROSIS; NORTH AMERICA; PATHOGENESIS; PHYSICAL DISABILITY; PREVALENCE; PROGNOSIS; RISK FACTOR; TREATMENT PLANNING;

EID: 2942674607     PISSN: 08732159     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0873-2159(15)30566-3     Document Type: Article

References (20)

1. BEHRSIN RF. Cirurgia redutora de volume pulmonar: critérios de seleção de pacientes no Hospital Universitário Antônio Pedro (dissertação de mestrado). Niterói: Universidade Federal Fluminense, 1999.
2. CARRELL RW, LOMAS DA. Alpha 1-Antitrypsin Deficiency - A Model for Conformational Diseases. New England Journal of Medicine 2002; 346 (1): 45-53.
3. COAKLEY RJ, TAGGART C, O'NEILL S, MCELVANEY N. G. α-1-Antitrypsin Deficiency: Biological Answers to Clinical Questions. The American Journal of the Medical Sciences 2001; 321 (1); 33-41.
4. CONSENSO BRASILEIRO DE DOENÇA PULMONAR OBSTRUTIVA CRÔNICA. J Pneumol 2000; 26 (Supl 1): S1-S56.
5. a ed. Rio de Janeiro: Revinter; 2001. p. 637-654.
6. CUVELIER A, MUIR J F, HELLOT MF, BENHAMOU D, MARTIN J P, BENICHOU J, SESBOUE R. Distribution of α-1-Antitrypsin Alleles in Patients with Bronchiectasis. Chest 2000; 117 (2): 415-9.
7. DAHL M, TYBJAERG-HANSEN A, LANGE P VESTBO J, NORDESTGAARD BG. Change in Lung Function and Morbidity from Chronic Obstructive Pulmonary Disease in α-1-Antitrypsin MZ Heterozygotes: A Longitudinal Study of General Population. Annals of Internal Medicine 2002; 136 (4): 270-9.
8. DAHL M, BORGE G, NORDESTGAARD BG, LANGE P, VESTBO J, TYBJAERG-HANSEN. Molecular Diagnosis of Intermediate and Severe α-1-Antitrypsin Deficiency: MZ Individuals with Chronic Obstructive Pulmonary Disease May Have Lower Lung Function than MM Individuals. Clinical Chemistry 2001; 47 (1): 56-62.
9. DOWSON LJ, GUEST PJ, HILL SL, STOCKLEY RA. High-resolution computed tomografy scanning in α-1-antitrypsin deficiency: relationship to lung function and health status. Eur Respir J 2001; 17 (6): 1097-1104.
10. EDEN E, MITCHELL D, MEHLMAN B, KHOULI H, NEJAT M, GRIECO MH, TURINO G M. Atopy, Asthma, and Emphysema in Pacients with Severe α-1-Antitrypsin Deficiency. American Journal of Respiratory Critical Care 1997; 156 (1): 68-74.
11. LAYDEN TJ, KULIK L. Hepatic manifestations of pulmonary diseases. Clin Liver Dis 2002; 6 (4): 969-79.
12. LUFT FC. Alpha1-antitrypsin and its relevance to human disease. J Mol Med 1999; 77 (4): 359-60.
13. MAHADEVA R, LOMAS DA. Genetics and respiratory disease 2. Alpha1-antitrypsin deficiency, cirrhosis and emphysema. Thorax 1998; 53 (6): 501-5.
14. NO AUTHORS LISTED: Summaries for pacients. Lung Function and Death from Chronic Obstructive Pulmonary Disease in α -1-Antitrypsin MZ Heterozygotes. Annals of Internal Medicine 2002; 136 (4 ): 135.
15. PITULAINEN E, TORNLING G, ERIKSSON S. Environmental correlares of impaired lung function in non-smokers with severe α-1-antitrypsin deficiency (PiZZ). Thorax 1998; 53 (11): 939-43.
16. PRIMHAK RA, TANNER MS. Alpha-1 antitrypsin deficiency. Arch Dis Child 2001; 85 (1): 2-5.
17. SANDHAUS RA. Alpha-1-Antitrypsin Deficiency Therapy: Pieces of the Puzzle. Chest, 2001 Mar; 119(3): 676-8.
18. STOCKLEY RA. Alpha-1-antitrypsin deficiency: what next? Thorax 2000; 55 (7): 614-8.
19. WEST J, RODMAN DM. Gene Therapy for Pulmonary Diseases. Chest 2001; 119 (2): 613-7.
20. WORLD HEALTH ORGANIZATION: α-1-Antitrypsin deficiency: Memorandum from a WHO meeting. Bulletin of the World Health Organization 1997; 75 (5): 397-415.